Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa

Summary

This study investigates efficacy, safety and pharmacokinetics of adalimumab in Japanese subjects with moderate to severe hidradenitis suppurativa (HS).

Timeline

Start

2016-09-06

Primary completion

2017-09-01

Completion

2019-05-30

Drugs

Indications